In draft diagnostics guidance published today for public consultation NICE has said that there is not enough evidence to recommend 3 new blood tests for speeding up the identification of bloodstream bacteria and fungi for routine use in the NHS.
30 September 2015
NICE has issued final draft guidance which recommends that idelalisib (marketed as Zydelig by Gilead Sciences) should be made available on the NHS for some adults with chronic lymphocytic leukaemia (CLL).
24 September 2015
In final guidance published today NICE has recommended the anti-blood clotting drug edoxaban (Lixiana, Daiichi Sankyo) as an option for preventing stroke and systemic embolism (blood clots) in adults with non-valvular atrial fibrillation (NVAF) who have one or more further risk factors.
23 September 2015
The National Institute for Health and Care Excellence (NICE) has published its first guideline for the social care sector to promote high-quality home care services for older people at a time when demand for such services is set to grow.
23 September 2015
New NICE guidance recommends a device that could save thousands of people from needing an invasive procedure to diagnose and monitor liver damage.
22 September 2015
The National Institute for Health and Care Excellence (NICE) has published an updated draft guideline on workplace policy and practices to help improve the health and wellbeing of all employees, including those aged 50 and over in paid or unpaid work.
18 September 2015
0300 323 0142
(this number rings all our phones and is the best number to contact us on 9:00 – 17:30 Mon - Fri)
(out of office hours number)
Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please contact a member of the team.